CIK 0001824893 · Non-accelerated filer<br>Smaller reporting company
Surrozen, Inc./DE
Sign in to watch- Ticker
- SRZN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 301374889
- Phone
- 650-475-2820
- Business address
- 171 OYSTER POINT BLVD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Consonance-HFW Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 54 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-15 | Parker Craig C Chief Executive Officer | Grant or award | +1,553 | $8.11 | $13K | 8,577 |
| 2025-12-05 | Kutzkey Tim Director | Purchase | +14,503 | $19.54 | $283K | 869,460 |
| 2025-12-05 | Kutzkey Tim Director | Purchase | +16,381 | $19.54 | $320K | 981,890 |
| 2025-12-05 | COLUMN GROUP III GP, LP 10% owner | Purchase | +14,503 | $19.54 | $283K | 869,460 |
| 2025-12-05 | COLUMN GROUP III GP, LP 10% owner | Purchase | +16,381 | $19.54 | $320K | 981,890 |
| 2025-12-04 | Kutzkey Tim Director | Purchase | +2,475 | $17.35 | $43K | 854,957 |
| 2025-12-04 | Kutzkey Tim Director | Purchase | +2,791 | $17.35 | $48K | 965,509 |
| 2025-12-04 | COLUMN GROUP III GP, LP 10% owner | Purchase | +2,475 | $17.35 | $43K | 854,957 |
| 2025-12-04 | COLUMN GROUP III GP, LP 10% owner | Purchase | +2,791 | $17.35 | $48K | 965,509 |
| 2025-11-13 | Kutzkey Tim Director | Purchase | +148,150 | $12.65 | $1.9M | 852,482 |
| 2025-11-13 | Kutzkey Tim Director | Purchase | +167,307 | $12.65 | $2.1M | 962,718 |
| 2025-11-13 | COLUMN GROUP III GP, LP 10% owner | Purchase | +148,150 | $12.65 | $1.9M | 852,482 |
| 2025-11-13 | COLUMN GROUP III GP, LP 10% owner | Purchase | +167,307 | $12.65 | $2.1M | 962,718 |
| 2025-11-12 | Maleki Andrew Pedrum Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-06-13 | Li Yang Exec. Vice President, Research | Grant or award | +400 | $8.06 | $3K | 13,043 |
| 2025-06-13 | Williams Charles O CFO and COO | Grant or award | +400 | $8.06 | $3K | 9,382 |
| 2025-06-13 | Parker Craig C Chief Executive Officer | Grant or award | +400 | $8.06 | $3K | 7,024 |
| 2025-05-14 | BJERKHOLT ERIC Director | Grant or award · Option (right to buy) | +1,333 | 1,333 | ||
| 2025-05-14 | CHAI CHRISTOPHER Y Director | Grant or award · Option (right to buy) | +1,333 | 1,333 | ||
| 2025-05-14 | Haak-Frendscho Mary Director | Grant or award · Option (right to buy) | +1,333 | 1,333 |
Page 6 of 12 · 237 trades